PPT-Antiplatelet therapy in CAD

Minilecture Objectives Indications for Antiplatelet Therapy in patients with CAD and ACS Antiplatelet Therapy in the role of primary and secondary prevention of c ardiovascular events CAD amp the Vulnerable Plaque. V Kamakoti Department of Computer Science and Engineering Indian Institute of Technology Madras Chennai 600 036 India Email kamacsiitmernetin CAD for VLSI DESIGN I CAD for VLSI Design I Course Starts Here All The Best CAD for VLSI DESIGN I Evo Yogesh Kulkarni. Software Development Manager, Autodesk, Pune, India. Speaker’s Bio-data. Currently, Software . Development Manager at Autodesk, Pune, . India. Before . Autodesk. , . worked . in companies like PTC, SDRC, UGS, with total CAD software development experience of about 14-15 years.. Therapy for Secondary Prevention . Beyond One Year . Following . ACS or PCI. Working Group. : . Anil Gupta MD, FRCPC, Pierre Theroux MD, FRCPC . Canadian Cardiovascular Society Antiplatelet Guidelines. Which specific people might experience those advantages and disadvantages?. When designing a complicated assembly is it quicker to design by hand or in CAD?. Why? . Justify your answer.. Think about ease of drawing, use of different icons, ability to edit and save a drawing. Can drawings be sent directly to CAM machines.. Antiplatelet Guidelines. HEART FAILURE. Working Group: . Alan D. Bell, MD, CCFP; James D. . Douketis. , MD, FRCP. Objectives. Interpret . the . Canadian Cardiovascular Society Guideline . recommendations . (. PTS). Aleksandra . Seledkova. . Perm National Research Polytechnic University. The comparison of existing CAD systems for designing the power supply systems. CAD . system. Circuit diagram. Calculation of electrical parameters. M. . Ramanathan. Bio-CAD. Molecular surfaces. Bio-CAD. Molecular surfaces. Bio-CAD. Connolly surface. Bio-CAD. Bio-CAD. Molecular surface representation. Bio-CAD. Union of partial spheres and . tori. MSE 508/L SP08. Week 8. Jeffrey . Peltz. Yang . Xie. Gurucharan. Singh. 1. CAD in Entertainment. Typhoon – A Roller Coaster Emerges. Gerstlauer. . Elektro. GmbH. a roller coaster design firm was given six months to design the first version of Euro Fighter. CAD was utilized throughout the entire process replacing paperwork that is no longer feasible in roller coaster design. Over 3000 man hours went into design and production was started in the summer of 2003. Thomas Savides, M.D.. Professor of Clinical Medicine. University of California, San Diego. Disclosures. None. Learning Objectives. Accurately assess the risk of bleeding in patients on anticoagulants and antiplatelet agents before endoscopic procedures. Stratified by Baseline CV Risk Category. Aspirin for Secondary Prevention of CV Disease. Anticoagulant Therapy in CAD. Warfarin -- WARIS-2. ATLAS ACS 2 -- TIMI 51. Rivaroxaban vs Placebo After ACS. COMPASS. Management of Anticoagulants & Antiplatelet Agents Pre and Post Endoscopy Thomas Savides, M.D. Professor of Clinical Medicine University of California, San Diego Disclosures None Learning Objectives Anticoagulant therapy. (n = . 124). CADISS. P. rimary outcome. : . Ipsilateral . stroke or all-cause mortality . for antiplatelet vs. anticoagulation: 2. % . vs. 1%; p . = . 0.63. Any stroke: 2% vs. 1%, . People with diabetes have a 2 to 4 fold higher risk of dying from cardiovascular disease. People with diabetes have a complex procoagulant state, which contributes to the increased risk of atheroscler intracerebral haemorrhage (ICH): extended follow-up of the. RE. start. or . ST. op. . A. ntithrombotics. . R. andomised . T. rial. (RESTART) . RESTART Collaboration. www.RESTARTtrial.org. Intracerebral haemorrhage (ICH) is associated with an increased risk of arterial ischaemic events*: pooled analysis of 4 population-based cohorts.